This means oncologists do not want to be sticking needles in people for biopsies because it creates more inflammation and also because when one punctures tumors to see what they are cancer cells can be released out of their containment vessel (the tumor).
Biopsies have been around for years and who knows, in the years to come, maybe it will be possible to forego 90% of biopsies, as antibody/blood tests come online that will become sufficient.
There are about 1.5 Million liver biopsies completed earch year in the U.S. alone.
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!